Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
222 Leser
Artikel bewerten:
(0)

SNOMED International's Global Patient Set: Navigating International Patient Care and Interoperability

LONDON, April 17, 2019 (GLOBE NEWSWIRE) -- At SNOMED International's April Business Meeting held in London last week, the organization announced to its Community of Practice the planned release of a Global Patient Set built from its globally recognized SNOMED CT clinical terminology standard.

SNOMED International will release the Global Patient Set, or GPS, to support the cross border movement of information, and ultimately health system interoperability. Once released, the GPS, a controlled list of existing SNOMED CT unique concept identifiers, single descriptions and reference sets, will be available to all interested parties at no cost to users.

The Chair of the organization's General Assembly, Lies van Gennip, is delighted to share with health systems and industry what the Global Patient Set provides to Members and non-Members alike. "The Global Patient Set enables easier specification of EHR requirements, e.g. a patient summary, and results in improved interoperability. The Set will also offer non-Members considering SNOMED CT use a mechanism for greater insight into the product and its value without requiring initial investment."

CEO, Don Sweete, emphasizes that the release of the GPS serves as a stepping stone to leverage the true value of SNOMED CT's polyhierarchical design. "An innovative offering, it is worth noting that the Global Patient Set offers a limited function of SNOMED CT. Providing a flat list of existing concepts and reference sets, the GPS is positioned to support cross border interoperability and enhanced digital maturity as users move towards decision support and full analytics capabilities in their respective strategies," said Sweete in his discussions with the SNOMED CT Community of Practice last week.

Chief among its advantages, SNOMED International Members benefit from a terminology that enables interoperability, reduced clinical risk, large scale public health reporting and research, along with a wealth of organization resources including education, tooling, creation of national extensions, representation on governance bodies, and dedicated on-boarding and user support.

Over the coming months, SNOMED International will formalize the steps and due diligence required to make the GPS offering available for release September 1, 2019. Throughout this period, SNOMED International will continue to define the Global Patient Set, from content through to its release and maintenance approach. Refer to SNOMED International's Global Patient Set resourcesto learn more as this initiative progresses. Subscribewith the organization's news service to keep up to date on developments as they occur.

For additional information, contact info@snomed.org.

About SNOMED International
SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, the world's most comprehensive healthcare terminology product. We play an essential role in improving the health of humankind by determining standards for a codified language that represents groups of clinical terms. This enables healthcare information to be exchanged globally for the benefit of patients and other stakeholders. We are committed to the rigorous evolution of our products and services, to deliver continuous innovation for the global healthcare community. SNOMED International is the trading name of the International Health Terminology Standards Development Organisation.
www.snomed.org

Media Inquiries:
Kelly Kuru, Executive Lead, Communications
SNOMED International
Telephone: +1-416-566-8725

© 2019 GlobeNewswire (Europe)
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.